| scholarly article | Q13442814 |
| P2093 | author name string | Aruni Bhatnagar | |
| Sanjay Srivastava | |||
| Krista A Riggs | |||
| Nalinie S Wickramasinghe | |||
| Srinivas D Sithu | |||
| Anuradha Kalani | |||
| Abhinav Agarwal | |||
| Daniel W Riggs | |||
| Marina V Malovichko | |||
| Millicent G Winner | |||
| Rihab E Hamed-Berair | |||
| P2860 | cites work | A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 |
| PCSK9: a key modulator of cardiovascular health | Q27027617 | ||
| Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy | Q28238421 | ||
| Apolipoprotein A-V; a potent triglyceride reducer | Q28245263 | ||
| Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol | Q28281468 | ||
| Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants | Q28504743 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| A receptor-mediated pathway for cholesterol homeostasis | Q29616158 | ||
| Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction | Q30301147 | ||
| Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic | Q33822165 | ||
| The role of the LDL receptor in apolipoprotein B secretion | Q33939089 | ||
| Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment | Q34048473 | ||
| Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
| Hypercholesterolemia and atherosclerosis in low density lipoprotein receptor mutant rats | Q34147069 | ||
| Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation | Q34260100 | ||
| Structure and physiologic function of the low-density lipoprotein receptor | Q34650688 | ||
| Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. | Q34756881 | ||
| Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs | Q35137644 | ||
| Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B | Q35830557 | ||
| Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells | Q35839578 | ||
| Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress | Q35879593 | ||
| Animal models of atherosclerosis | Q35903298 | ||
| PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE. | Q36196833 | ||
| Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice | Q36543639 | ||
| Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism | Q36756510 | ||
| Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype | Q37000190 | ||
| Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation | Q37250324 | ||
| Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue | Q37400729 | ||
| Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice | Q37406150 | ||
| Atherosclerosis: current pathogenesis and therapeutic options | Q37953777 | ||
| The genetics of familial combined hyperlipidaemia | Q37983699 | ||
| Physiological regulation of lipoprotein lipase | Q38203657 | ||
| Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. | Q38255828 | ||
| The molecular and cell biology of apolipoprotein-B. | Q38669547 | ||
| Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). | Q39366548 | ||
| AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction | Q40166461 | ||
| Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. | Q40445575 | ||
| Development of apolipoprotein E-deficient mice | Q41546267 | ||
| Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-ric | Q41664275 | ||
| PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver | Q42819209 | ||
| Ldlr-/- mice display decreased susceptibility to Western-type diet-induced obesity due to increased thermogenesis | Q42873437 | ||
| Increased secretion of lipoproteins in transgenic mice expressing human D374Y PCSK9 under physiological genetic control. | Q43071452 | ||
| PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities. | Q43212730 | ||
| LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice | Q43819543 | ||
| Decreased plasma adiponectin concentrations in women with dyslipidemia | Q44018162 | ||
| Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus | Q44205656 | ||
| Familial combined hyperlipidemia and abnormal lipoprotein lipase | Q44228581 | ||
| Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor. | Q44409144 | ||
| Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant | Q44937777 | ||
| Fenofibrate reduces tumor necrosis factor-alpha serum concentration and adipocyte secretion of hypercholesterolemic rabbits | Q45019678 | ||
| Atherosclerosis imaging and the future of lipid management | Q45176693 | ||
| Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia | Q46345830 | ||
| Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice | Q46405880 | ||
| Apolipoprotein B metabolism in homozygous familial hypercholesterolemia | Q46448687 | ||
| Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo | Q46843826 | ||
| ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis | Q47748338 | ||
| Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. | Q48315062 | ||
| Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. | Q51555890 | ||
| Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein | Q62383302 | ||
| Single vertical spin density gradient ultracentrifugation | Q69553503 | ||
| Regulated biosynthesis and divergent metabolism of three forms of hepatic apolipoprotein B in the rat | Q70061881 | ||
| Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia | Q71659785 | ||
| ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 | ||
| Cisplatin (CDDP)-induced acute toxicity in an experimental model of hepatic fibrosis | Q81039960 | ||
| Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD | Q81476257 | ||
| Effect of two intensive statin regimens on progression of coronary disease | Q82513300 | ||
| Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats | Q83789493 | ||
| P433 | issue | 9 | |
| P577 | publication date | 2017-05-04 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Atherogenesis and metabolic dysregulation in LDL receptor-knockout rats | |
| P478 | volume | 2 |
| Q89431399 | A Simple Method for Normalization of Aortic Contractility |
| Q92890715 | Alterations of lipid metabolism, blood pressure and fatty liver in spontaneously hypertensive rats transgenic for human cholesteryl ester transfer protein |
| Q64890933 | An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency. |
| Q64081103 | Generation of hyperlipidemic rabbit models using multiple sgRNAs targeted CRISPR/Cas9 gene editing system |
| Q64116189 | Knockout rat models mimicking human atherosclerosis created by Cpf1-mediated gene targeting |
| Q64055469 | Laminin promotes differentiation of rat embryonic stem cells into cardiomyocytes by activating the integrin/FAK/PI3K p85 pathway |
| Q58714883 | Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7 |
Search more.